Evidence map›Paper›PMID 34014809›Full record

ArticleAmerican journal of respiratory cell and molecular biology2021

Extracellular Vesicle TGF-β1 Is Linked to Cardiopulmonary Dysfunction in Human Immunodeficiency Virus.

Balaji Krishnamachary, Aatish Mahajan, Ashok Kumar, Stuti Agarwal, Aradhana Mohan, Ling Chen, Priscilla Y Hsue, Prabhakar Chalise, Alison Morris, Navneet K Dhillon

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Signaling pathways and targeted therapy for pulmonary hypertension.Signal transduction and targeted therapy · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Hitting the target: cell signaling pathways modulation by extracellular vesicles.Extracellular vesicles and circulating nucleic acids · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Plasma CD16mBio · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Balaji KrishnamacharyDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.
Aatish MahajanDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.
Ashok KumarDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.
Stuti AgarwalDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.
Aradhana MohanDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.
Ling ChenDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.
Priscilla Y HsueDepartment of Medicine, University of California San Francisco, San Francisco, California; and.
Prabhakar ChaliseDepartment of Biostatistics and Data Science, University of Kansas Medical Center, Kansas City, Kansas.
Alison MorrisDepartment of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Navneet K DhillonDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, and.ORCID 0000-0001-6582-5757
Pulmonary and Critical Care Associates · USUniversity of California, San Francisco · USUniversity of Kansas Medical Center · USUniversity of Pittsburgh · US

Funding

Transgenic & Gene-Targeting Shared ResourceP30CA168524 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NICOLE L NOLLEN · 2012 to 2026
$40.1M
Vascular Subphenotypes of Lung DiseaseP01HL103455 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLADWIN, MARK T · 2011 to 2020
$26.1M
Using Integrated Omics to Identify Dysfunctional Genetic Mechanisms Influencing Schizophrenia and Sleep DisturbancesP20GM130423 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ANDREW K. GODWIN · 2019 to 2026
$21.5M
Transgenic and Gener-Targeting CoreP20GM104936 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SAADI, IRFAN · 2012 to 2016
$10.9M
Novel Approaches for the Control of Microbial PathogensP30GM103326 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LUTKENHAUS, JOSEPH F · 2012 to 2016
$5.3M
Translational evaluation of aging, inflammation, and HIV in lung dysfunctionR01HL120398 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MORRIS, ALISON · 2013 to 2017
$3.4M
Longitudinal evaluation of HIV-associated lung disease phenotypesR01HL125049 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MELLORS, JOHN W, MORRIS, ALISON · 2014 to 2017
$3.3M
Drug abuse and HIV-associated pulmonary vascular injuryR01HL152832 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DHILLON, NAVNEET KAUR · 2021 to 2024
$2.8M
Extracellular Vesicles and and HIV/cocaine associated cardiopulmonary dysfunctionR01DA042715 · NIDA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DHILLON, NAVNEET KAUR · 2016 to 2020
$2.2M
Impact of Opiate abuse on HIV-mediated Pulmonary Vascular RemodelingR01HL129875 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DHILLON, NAVNEET KAUR · 2016 to 2018
$1.5M
HIV/Cocaine mediated human pulmonary vascular remodeling: Role of BMPR signaling.R01DA034542 · NIDA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DHILLON, NAVNEET KAUR · 2012 to 2016
$1.5M
JEOL JEM-1400 Transmission Electron Microscope with AMT-XR611M Digital Camera SysS10RR027564 · NCRR · UNIVERSITY OF KANSAS MEDICAL CENTER · PI ABRAHAMSON, DALE R · 2010 to 2010
$418k
NCI NIH HHS P30 CA168524NCRR NIH HHS S10 RR027564NHLBI NIH HHS P01 HL103455NHLBI NIH HHS R01 HL120398NHLBI NIH HHS R01 HL125049NHLBI NIH HHS R01 HL129875NHLBI NIH HHS R01 HL152832NIDA NIH HHS R01 DA034542NIDA NIH HHS R01 DA042715NIGMS NIH HHS P20 GM104936NIGMS NIH HHS P20 GM130423NIGMS NIH HHS P30 GM103326
6 · The paper itself

Abstract

Extracellular vesicles (EVs) have emerged as important mediators in cell-cell communication; however, their relevance in pulmonary hypertension (PH) secondary to human immunodeficiency virus (HIV) infection is yet to be explored. Considering that circulating monocytes are the source of the increased number of perivascular macrophages surrounding the remodeled vessels in PH, this study aimed to identify the role of circulating small EVs and EVs released by HIV-infected human monocyte-derived macrophages in the development of PH. We report significantly higher numbers of plasma-derived EVs carrying higher levels of TGF-β1 (transforming growth factor-β1) in HIV-positive individuals with PH compared with individuals without PH. Importantly, levels of these TGF-β1-loaded, plasma-derived EVs correlated with pulmonary arterial systolic pressures and CD4 counts but did not correlate with the Dl

Indexed as

AnimalsExtracellular VesiclesHIVHIV InfectionsHumansHypertension, PulmonaryMacrophagesMaleMonocytesPulmonary Arterial HypertensionRatsRats, Inbred F344Receptors, Transforming Growth Factor betaTransforming Growth Factor beta1Vascular RemodelingReceptors, Transforming Growth Factor betaTGFB1 protein, humanTransforming Growth Factor beta1endothelial injuryinflammationmonocytespulmonary hypertensionsmooth muscle dysfunction

Identifiers

PMID34014809
PMCPMC8525206
OpenAlexW3161173338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.